SynthesisJournal of cancer research and clinical oncology2021

Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials.

Wanting Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.